Doc No	Title	Issue date
09101622	Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone	Aug 11, 2015
09101621	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation	Aug 11, 2015
08759375	Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor	Jun 24, 2014
08673939	Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione	Mar 18, 2014
08648095	Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor	Feb 11, 2014
08632787	Methods using immunomodulatory compounds for treatment of certain leukemias	Jan 21, 2014
08530498	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione	Sep 10, 2013
08492406	Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione	Jul 23, 2013
08440194	Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias	May 14, 2013
08410136	Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione	Apr 2, 2013
08207200	Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation	Jun 26, 2012
08198306	Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor	Jun 12, 2012
08198262	Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione	Jun 12, 2012
08188118	Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies	May 29, 2012
07968569	Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione	Jun 28, 2011
07855217	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 21, 2010
07468363	Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 23, 2008
07465800	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 16, 2008
07435745	Methods and compositions for inhibition of angiogenesis	Oct 14, 2008
07393862	Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias	Jul 1, 2008
07323479	Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline	Jan 29, 2008
07189740	Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes	Mar 13, 2007
06673828	Analogs of 2-Phthalimidinoglutaric acid	Jan 6, 2004
06555554	Isoindolines, method of use, and pharmaceutical compositions	Apr 29, 2003
06518298	Methods and compositions for inhibition of angiogenesis with EM-138	Feb 11, 2003
06476052	Isoindolines, method of use, and pharmaceutical compositions	Nov 5, 2002
06469045	Methods and compositions for inhibition of angiogenesis with EM-138	Oct 22, 2002
06458810	Pharmaceutically active isoindoline derivatives	Oct 1, 2002
06420414	Amino derivatives of EM-138 and methods of treating angiogenesis with same	Jul 16, 2002
06403613	1-oxo-and 1,3-dioxoisoindolines	Jun 11, 2002
06395754	Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNF levels	May 28, 2002
06380239	Substituted 1-oxo- and 1,3-dioxoisoindoline and method of reducing inflammatory cytokine levels	Apr 30, 2002
06335349	Substituted 2(2,6-dioxopiperidin-3-yl)isoindolines	Jan 1, 2002
06326388	Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level	Dec 4, 2001
06316471	Isoindolines, method of use, and pharmaceutical compositions	Nov 13, 2001
06281230	Isoindolines, method of use, and pharmaceutical compositions	Aug 28, 2001
06235756	Methods and compositions for inhibition of angiogenesis by thalidomide	May 22, 2001
06228879	Methods and compositions for inhibition of angiogenesis	May 8, 2001
06140346	Treatment of cancer with thalidomide alone or in combination with other anti-cancer agents	Oct 31, 2000
06114335	Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines	Sep 5, 2000
06114355	Methods and compositions for inhibition of angiogenesis	Sep 5, 2000
06071948	Methods and compositions for inhibition of angiogenesis	Jun 6, 2000
06020358	Substituted phenethylsulfones and method of reducing TNF.alpha. levels	Feb 1, 2000
05955476	Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels	Sep 21, 1999
05929117	Immunotherapeutic agents	Jul 27, 1999
05877200	Cyclic amides	Mar 2, 1999
05874448	Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNF.alpha. levels	Feb 23, 1999
05798368	Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNF.alpha. levels	Aug 25, 1998
05733566	Controlled release of antiparasitic agents in animals	Mar 31, 1998
05731325	Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents	Mar 24, 1998
05712291	Methods and compositions for inhibition of angiogenesis	Jan 27, 1998
05698579	Cyclic amides	Dec 16, 1997
05674533	Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension	Oct 7, 1997
05639476	Controlled release formulations coated with aqueous dispersions of acrylic polymers	Jun 17, 1997
05635517	Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines	Jun 3, 1997
05629327	Methods and compositions for inhibition of angiogenesis	May 13, 1997
05593990	Methods and compositions for inhibition of angiogenesis	Jan 14, 1997
05591767	Liquid reservoir transdermal patch for the administration of ketorolac	Jan 7, 1997
05580755	Human pluripotent granulocyte colony-stimulating factor	Dec 3, 1996
05528823	Method for retaining wires in a current mode coupler	Jun 25, 1996
05393870	Analogs of human granulocyte-macrophage colony stimulating factor	Feb 28, 1995
05391485	DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues	Feb 21, 1995
05387421	Multi stage drug delivery system	Feb 7, 1995
05385901	Method of treating abnormal concentrations of TNF .alpha.	Jan 31, 1995
05354556	Controlled release powder and process for its preparation	Oct 11, 1994
05325388	Optoelectronic waveguide neural architecture	Jun 28, 1994
05229496	Analogs of human granulocyte-macrophage colony stimulating factor	Jul 20, 1993
05140345	Method of manufacturing a substrate for a liquid jet recording head and substrate manufactured by the method	Aug 18, 1992
05134127	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof	Jul 28, 1992
05120548	Swelling modulated polymeric drug delivery device	Jun 9, 1992
05073543	Controlled release formulations of trophic factors in ganglioside-lipsome vehicle	Dec 17, 1991
05071948	Polyamide-polyimide and polybenzoxazole-polyimide polymer	Dec 10, 1991
05059595	Pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in controlled-release form active in the therapy of organic mental disturbances	Oct 22, 1991
05020353	Method of machining an oblong workpiece and a machine for performing the method	Jun 4, 1991
05001116	Inhibition of angiogenesis	Mar 19, 1991

Lawsuits

CELGENE CORPORATION v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Summary

Plaintiff

Defendant

Plaintiff Attorneys

Defendant Attorneys

Counter Defendant

Counter Claimant

Cause

Related Patents